Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Reese Marketos played the role of government prosecutor in a False Claims Act case about alleged off-label use of an HIV drug ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, expectations were $2.58. Operator: Good morning, and welcome to Johnson & ...

Johnson & Johnson maintained its full-year 2025 adjusted earnings outlook of $10.50 to $10.70 a share, or 6.2% growth from a year ago at the midpoint.

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Bryan Johnson, the anti-aging influencer, halted his Rapamycin regimen after five years due to adverse side effects like ...

Stocks to Watch. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other ...

EXCLUSIVE: Sens. Ron Johnson and Chuck Grassley are demanding information from the Justice Department’s inspector general on whether any unassigned, or "untasked," confidential human sources from DOJ ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.